Lamisil

---

On May 9, 2001, the FDA announced a significant safety-related update to the labeling of Lamisil after it reviewed 16 cases of liver failure, that resulted in 11 deaths and two liver transplants. The agency concluded that these liver conditions might have been caused by Lamisil.

Lamisil, also known as terbinafine hydrochloride, is used to treat onychomycosis (fungal infections). It comes in a tablet form to treat fungal nail infections, and in a cream form to treat other fungal infections such as athlete's foot, jock itch, and ringworm.

Common side-effects include diarrhea, indigestion and rash. In rare cases Lamisil tablets could cause liver damage in some patients.

If you or a loved one has suffered an injury as a result of taking any drug or supplement, call The Law Offices of Rosenberg, Kirby, Cahill & Stankowitz now at (732) 341-3337 or CLICK HERE TO SUBMIT A SIMPLE CASE FORM. The initial consultation is free of charge, and if we agree to review your case, we will work on a contingent fee basis, which means we get paid for our services only if there is a monetary award or recovery of funds. Don't delay! You may have a valid claim and be entitled to compensation for your injuries, but a lawsuit must be filed before the statute of limitations expires.

	July 1, 2001 - Safety Alert Issued On Sporanox And Lamisil
	May 9, 2001 - Public Health Advisory: Novartis Pharmaceutical

The above is not legal advice. That can only come from a qualified attorney who is familiar with all the facts and circumstances of a particular, specific case and the relevant law. See Terms of Use.